Mirae Asset Global Investments Co., Ltd. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 285 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,066,813
-15.8%
286,743
+8.6%
0.02%
-13.0%
Q2 2023$10,771,195
+32.7%
264,110
+21.3%
0.02%
+21.1%
Q1 2023$8,114,759
+11.7%
217,729
+4.5%
0.02%0.0%
Q4 2022$7,266,575
-38.6%
208,271
-1.5%
0.02%
-40.6%
Q3 2022$11,831,000
+27.3%
211,423
+17.8%
0.03%
+33.3%
Q2 2022$9,292,000
-15.7%
179,525
+18.3%
0.02%
+100.0%
Q1 2022$11,028,000
+4.1%
151,748
+69.4%
0.01%
-47.8%
Q4 2021$10,592,000
-43.2%
89,581
-35.6%
0.02%
-51.1%
Q3 2021$18,648,000
+2.0%
139,015
+23.1%
0.05%
-7.8%
Q2 2021$18,279,000
+104.6%
112,902
+1.4%
0.05%
+64.5%
Q1 2021$8,933,000
+170.1%
111,298
+83.0%
0.03%
+158.3%
Q4 2020$3,307,000
+348.1%
60,802
+63.9%
0.01%
+200.0%
Q3 2020$738,000
+38.7%
37,102
+46.6%
0.00%
+33.3%
Q2 2020$532,000
+178.5%
25,307
+61.6%
0.00%
+200.0%
Q1 2020$191,000
-6.8%
15,656
+12.2%
0.00%0.0%
Q4 2019$205,000
+45.4%
13,954
+32.3%
0.00%0.0%
Q3 2019$141,00010,5470.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders